Abstract
Previous studies have demonstrated that cocaine-induced behavioral sensitization is associated with persistent functional and structural alterations in the medial prefrontal cortex (mPFC) and nucleus accumbens (NAc); however, the molecular mechanisms underlying these changes have not been elucidated. In this study, the behavioral sensitization to cocaine was established in Sprague Dawley rats and was measured by locomotion and behavioral rating. The brain tissue homogenization was used for measuring the level of brain-derived neurotrophic factor (BDNF), the expression and activity of integrin-linked kinase (ILK), level of protein kinase B (Akt) phosphorylation at serine 473 and threonine 308 and the expression of p75NTR, TrkA and TrkB protein. The Results showed that cocaine sensitization was associated with increased BDNF, ILK activity, phospho-Akt Ser473, p75NTR and TrkB protein levels in the mPFC and NAc core. The combination of pergolide and ondansetron normalized not only behavioral sensitization, but also the increases in these molecular markers. Dual immunofluoresence staining showed that ILK expression is co-distributed with p75NTR and TrkA expression in both the mPFC and NAc core. Results suggested that the BDNF-TrkA/p75NTR-ILK-Akt signaling pathway may be active in cocaine sensitization and associated neural plasticity in the mPFC and NAc core.
Similar content being viewed by others
Introduction
Although numerous preclinical and clinical studies have been conducted to identify treatment regimens that promote long-term abstinence in chronic cocaine abusers, few treatments have shown consistent efficacy1. This is because the molecular mechanisms driving the alterations in neurological plasticity commonly seen in cocaine abusers, related to their vulnerability to episodes of craving, have not been elucidated2. Thus, elucidation of the molecular basis of this vulnerability is expected to help identify effective treatment targets. Previous studies have demonstrated that brain-derived neurotrophic factor (BDNF) is a key protein involved in synaptic plasticity within the central nervous system3,4. BDNF is also implicated in long-term behavioral sensitization to psychostimulants5,6,7. For example, withdrawal from cocaine self-administration significantly increases the levels of BDNF in the ventral tegmental area (VTA), nucleus accumbens (NAc) and amygdala8. In addition, direct infusion of BDNF into the VTA or dorsomedial prefrontal cortex of rodents induced long-lasting enhancement of cocaine seeking9 or cocaine self-administration-induced elevation of p-synapsin in nucleus accumbens10. BDNF has been demonstrated to exert its effects through activation of various signal transduction pathways, including those involving phosphatidylinositol-3-kinase (PI3 K), mitogen-activated kinase (MAPK) and phospholipase C-γ11,12.
Currently identified neurotrophin receptors include the tyrosine kinase (Trk) receptors, such as TrkA, TrkB, TrkC and the common neurotrophin receptor p75NTR13. Different neurotrophins have been shown to interact differently with these receptors. For example, all proneurotrophins and matured neurotrophins bind to and activate p75NTR. In contrast, no proneurotrophin binds to Trk receptors. The mature neurotrophins exhibit more specific interaction with the 3 Trk receptors, such as the main interaction of NGF with TrkA, the interaction of BDNF and NT4 with TrkB and the interaction of NT3 with TrkC14. However, BDNF has been revealed to bind all neurotrophin receptors13. It has been revealed that p75NTR can be found in a complex with Trk receptors to conduct neurotrophin signaling for neural survival15. For example, a study in PC12 cells showed that co-expression of p75NTR with TrkA can enhance NGF-induced neurite outgrowth and survival16. Another study in oligodendrocytes showed that treatment with BDNF can stimulate p75NTR and TrkA, but not TrkB receptor expression17.
The available evidence suggests that alterations in PI3 K/protein kinase B (Akt) signaling may contribute to the expression and maintenance of behavioral sensitization18,19. PI3K-mediated full activation of Akt requires phosphorylation at both the Thr308 and Ser473 residues. Besides PI3K, integrin-linked kinase (ILK), an upstream kinase of Akt, is also responsible for PI3K-dependent Akt Ser473 phosphorylation20. ILK has been demonstrated to be located in neuronal cell bodies and dendrites in various brain regions21,22. Furthermore, ILK may play key roles in divergent processes in the central nervous system, such as neurite outgrowth, survival of neurons and myelination by oligodendrocytes23,24,25,26.
Previous studies have demonstrated that the 5-HT3 antagonist ondansetron or the D1/D2 agonist pergolide, when given after cocaine administration, can reverse previously-established cocaine sensitization27,28 with a reversal in the expression of selected molecular markers, such as NMDA (N-methyl-D-aspartic acid) and AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors28. In the present study, we investigated whether the levels of BDNF, TrkA, TrkB, p75NTR, Akt and ILK proteins also exhibit characteristic changes following the establishment of cocaine sensitization and whether their expressions could be blocked.
Materials and Methods
Animals and Drugs
Male Sprague-Dawley rats (SLAC LABORATORY ANIMAL Inc., Shanghai, China), initially weighing 150–200 g, were housed in pairs in the animal facility of Central South University on a 12-h light/dark cycle for 1 week prior to the experiments. Rats were then housed individually after initial vehicle or cocaine injection. All experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and Chinese legislation on the use and care of laboratory animals. All efforts were made to minimize animal suffering, to reduce the number of animals used and to utilize alternatives to in vivo techniques. All experimental protocol were approved by the Institutional Committee of Central South University
Cocaine HCl (Qinghai Pharmaceutical Factory, China), ondansetron hydrochloride dihydrate (GlaxoSmithkline, Research Triangle Park, NC) and pergolide (Sigma, St. Louis, MO) were prepared as described28.
Experimental Groups and Behavioral Measurements
Animals were treated as previously described28. Briefly, rats received 25 mg/kg/day cocaine (s.c.) for 5 consecutive days, followed by withdrawal for 9 days to establish long-term cocaine sensitization, or rats received saline injections plus 9 days of withdrawal. Starting on day 10 of withdrawal, half of the rats that received cocaine (C-P/O) or saline (S-P/O) injections were given 0.1 mg/kg pergolide, followed by 0.2 mg/kg ondansetron (s.c.) 3.5 h later for 5 consecutive days. The other half of the rats in the cocaine (C-D/S) and saline groups (S-D/S) received parallel vehicle injections for 5 consecutive days. All animals were then subjected to 9 days of withdrawal, followed by a challenge injection of 7.5 mg/kg cocaine (i.p.) (Fig. 1). Animals were then immediately returned to their home cages. The locomotion and behavioral rating scores were monitored over the next 60 min as previously described28. The baseline of locomotion in all animals was measured 1 day before cocaine injection. The behavioral score was given as 1 = asleep, 2 = almost asleep, 3 = dystonia, 4 = inactive, 5 = in-place oral behavior, 6 = grooming, 7 = normal-active movement, 8 = hyperactive, 9 = slow-patterned movement, 10 = fast-patterned movement and 11 = stereotypy.
Brain Dissection and Protein Measurement
Rats were euthanized and decapitated 24 h after the acute cocaine challenge. Brains were rapidly removed and sectioned for 1 mm coronal sections for medial prefrontal cortex (mPFC), caudate putamen (CPU), nucleus accumbens (NAc) core, NAc shell and amygdala. Especially, mPFC was taken at +3.2 to +2.2 mm; CPU, NAc core and NAc shell at +2.0 to +1.0 mm; and amygdala at −2.3 to −3.3 mm28. The tissue below the commissure was sectioned with the most ventral part designated as the NAc shell and the dorsal portion as the NAc core. Samples were stored at −80 oC until protein extraction.
BDNF Protein
BDNF levels in brain tissue lysates were measured using the BDNF Emax ImmunoAssay System kit (Promega, Madison, WI) according to the manufacturer’s instructions. The brain tissue lysates were diluted 1:4 with sample buffer provided with the kit. The BDNF standard curve was run for each plate (linear range: 7.8-500 pg/ml BDNF) and samples from a given brain area were determined in single assays.
Western Blots
Western blots were performed as previously described28. The primary antibody [anti-ILK 1:1000; anti-phospho-Akt (Ser473)1:1000; anti-phospho-Akt (Thr308) 1:1000; anti-Akt 1:1000] and peroxidase-labeled secondary antibody (1:2000 dilution) were purchased from Cell Signaling Technology (Berverly, MA). The rabbit anti-TrkA, anti-TrkB antibodies and anti-p75NTR antibody were purchased from Millipore (1:1000 dilution, Temecula, CA). The blot was developed with chemiluminescent substrate (Santa Cruz Biotechnology, Santa Cruz, CA). To control for loading efficiency, the blots were stripped and re-probed with α-tubulin antibody (1:1000 dilution; Abcam, Cambridge, MA) and expression levels of total ILK and phospho-Akt proteins were normalized to that of α-tubulin.
ILK Activity Assay
ILK activity assay was conducted as previously described29, but with some modifications. Briefly, tissue lysates (100 μg) were incubated with 2 μg anti-ILK antibody (Millipore, Temecula, CA) or IgG as a negative control overnight at 4 °C, followed by addition of 50 μl protein A/G PLUS agarose beads (Santa Cruz Biotechnology) and continual incubation for 2 h at 4 °C. The immune complex was isolated by centrifugation, washed 5× with 1-ml homogenate buffer and then 2x subsequently with kinase reaction buffer. Kinase activity was determined by incubating the immunoprecipitated complex with 1 μg of inactive Akt-GST agarose (Millipore) and 200 μM of ATP in reaction buffer for 1 h at 30 °C. ILK activity was determined by Western blot of Akt-GST phosphorylation using the site-specific anti-phospho-Akt (Ser473) antibody (Cell Signaling).
Immunofluorescence
After euthanization of rats and excision of rat brains, rat brains were soaked with 10% paraformaldehyde for 2 days and then with sucrose-infiltration solution (25% sucrose/PBS) for 24–30 hrs at 4 °C. The dual immunofluorescence staining was performed using free-floating coronal sections (15 μm). Briefly, sections were permeabilized with 10% normal goat serum containing 0.1% Triton X-100 for 2 hrs at room temperature. After rinsing sections briefly with PBS, sections were boiled in 10 mM citrate buffer (pH3.0) for antigen retrieval for 30 min and then incubated with primary antibodies [mouse anti-ILK antibody (1:100 dilution) plus rabbit anti-TrkA antibody (1:100), or rabbit anti-p75NTR antibody (1:100)] overnight at 4 °C. After washing, sections were incubated with goat anti-rabbit Cy3 conjugated antibody (1:100, Millipore), or goat anti-mouse FITC conjugated antibody (1:100, Millipore) for 2 hr at room temperature and then sections were washed with PBST and mounted with anti-fade medium (Vector Laboratories).
Data analyses
The data were presented as means and standard errors of the mean and were analyzed using the Statistical Package for the Social Sciences, Version 20.0. The ambulation and biochemical results were analyzed using one-way ANOVA, while repeated measures ANOVA was used for the behavioral rating scores. The post-hoc analyses were performed using Bonferroni corrected pair-wise comparisons. A p < 0.05 was considered statistically significant.
Results
BDNF Changes in the mPFC and NAc Core Parallel Behavioral Sensitization to Cocaine
ANOVA revealed significant effects of treatments on ambulation [F(3,34) = 6.724, p < 0.001]. The C-D/S animals had significantly higher ambulation in response to cocaine challenge than the S-D/S (p < 0.001), S-P/O (p < 0.01) and C-P/O (p < 0.015) groups (Fig. 2a). The behavioral rating scores (Fig. 2b) were repeated measured by ANOVA. Significant main effects of time [F(11,374) = 32.58, p < 0.001] and a significant time by treatment interaction [F(33,374) = 3.86, p < 0.001) were observed. The Bonferroni test showed significantly higher scores in the C-D/S animals at 30, 35, 50, 55 and 60 min post-challenge compared to all other groups (ps < 0.05). Moreover, pergolide/ondansetron treatment (C-P/O) significantly reduced behavioral rating scores at 30, 35, 40, 50, 55 and 60 min compared to the C-D/S animals (ps < 0.05).
To determine whether these long-term changes in the brain could be blocked, BDNF levels in the mPFC, NAc core, NAc shell, CPU and amygdala were measured using ELISA. No significant treatment effects were detected in the NAc shell, CPU, or amygdala (Table 1). In contrast, ANOVA revealed significant treatment effects on BDNF levels in the mPFC [F(3,31) = 19.197, p < 0.001] and NAc core [F(3,31) = 45.460, p < 0.001] (Fig. 2c,d). BDNF levels were significantly increased in the mPFC (p < 0.001) and NAc core (p < 0.001) in the sensitized (C-D/S) rats compared to rats in all other groups. Importantly, pergolide/ondansetron treatment (C-P/O) significantly normalized BDNF levels in the mPFC and NAc core. These findings suggest that: 1) cocaine sensitization selectively leads to long-term increases (>23 days after last cocaine injection, C-D/S group) in concentrations of BDNF in the mPFC and NAc core; and 2) combined pergolide/ondansetron treatment not only blocks the behavioral sensitization, but also normalizes BDNF levels in these two brain areas.
Cocaine Sensitization Increases ILK Protein and Phospho-Ser473 Akt Levels in the mPFC and NAc Core
A previous study demonstrated that ILK is involved in cocaine sensitization30. Whether ILK levels parallel BDNF concentrations in the mPFC and NAc core has not been previously reported. Western blot showed that no changes were observed in ILK protein expression levels in the CPU, NAc shell, or amygdala, following establishment of cocaine sensitization (Table 1). In contrast, significant group differences were observed in the mPFC [F(3,31) = 11.155, p < 0.001] and NAc core [F(3,31) = 29.961, p < 0.001] (Fig. 3a,b). In the mPFC, ILK levels were significantly higher in the C-D/S group than in the S-D/S (p < 0.001), S-P/O (p < 0.001) and C-P/O groups (p < 0.001). Pergolide/ondansetron treatment (C-P/O) significantly normalized ILK levels in cocaine sensitized rats. Similar to the finding in the mPFC, ILK levels in the NAc core were significantly higher in C-D/S animals than in the other three groups (ps < 0.001) (Fig. 3b). We further investigated whether the changes in ILK expression resulted in parallel changes in ILK activity. Cocaine sensitization increased ILK activity (Fig. 3c, p < 0.05) which correlated with ILK expression (Fig. 3d) in the mPFC. This suggested that ILK activity is related to the ILK protein level.
Total Akt levels were not significantly altered among all animals in any tested brain areas (Table 1). In contrast, phospho-Ser473-Akt levels (normalized to total Akt protein) exhibited significant treatment effects in the mPFC and NAc core (Fig. 4a,b). One-way ANOVA revealed that levels of phospho-Ser473 Akt in the mPFC [F(3,31) = 15.545, p < 0.001] and NAc core [F(3,31) = 17.615, p < 0.001] were significantly different among treatment groups, but not in the CPU, NAc shell, or amygdala (Table 1). Bonferroni tests demonstrated that the relative levels of Akt Ser473 phosphorylation were increased in the mPFC of C-D/S rats compared to those in the S-D/S (p < 0.001) and C-P/O groups (p < 0.001), but not in the S-P/O group (Fig. 4a). In the NAc core, post-hoc analyses revealed that the level of Akt Ser473 phosphorylation was significantly higher in the C-D/S group than in all other groups (p < 0.001) (Fig. 4b). These changes in the levels of phospho-Ser473 Akt and ILK in the mPFC and NAc core parallel changes in the levels of BDNF protein in the same brain regions. In contrast, phosph-Thr308 Akt levels were not significantly different between groups in both the mPFC (Fig. 4c) and NAc core (Fig. 4d).
Cocaine Sensitization Increases TrkB and p75NTR Protein Levels in the mPFC and NAc Core
It is well known that BDNF binds to the TrkB receptor and activates several signal pathways, including PI3K-Akt11. A previous study demonstrated that BDNF-mediated activation of ILK-Akt signaling requires co-expression of TrkA and p75NTR receptors12. TrkA, TrkB and p75NTR expression were measured in brain tissues. No significant differences in TrkA, TrkB and p75NTR expression were observed in the CPU, NAc shell, or amygdala following establishment of cocaine sensitization (Table 1). In contrast, significant group differences in TrkB levels were observed in the mPFC [F(3,31) = 11.155, p < 0.001] and NAc core [F(3,31) = 19.961, p < 0.001] (Fig. 5A,B). In the mPFC, TrkB level was elevated in the C-D/S group relative to those in the S-D/S, S-P/O and C-P/O groups (p < 0.001). The C-P/O group was not statistically different from either the S-D/S or S-P/O group (Fig. 5a). Similar to its levels in the mPFC, TrkB levels in the NAc core for C-D/S animals were enhanced compared to those in the other three groups (p < 0.001), which were not different from one another (Fig. 5b). In contrast, no significant group differences or significant differences in TrkA levels in the mPFC (Fig. 5c) and NAc core (Fig. 5d) between groups (p > 0.05) were observed. Significant group differences in p75NTR levels were observed in the mPFC [F(3,31) = 15.343, p < 0.001] and NAc core [F(3,31) = 17.163, p < 0.001] (Fig. 5e,f). In the mPFC and NAc core, p75NTR level was elevated in the C-D/S group relative to those in the S-D/S, S-P/O and C-P/O groups (p < 0.001). The C-P/O group was not statistically different from either the S-D/S or S-P/O group (Fig. 5e,f).
TrkA and p75NTR co-locate with ILK Expression
Previous studies have demonstrated that ILK is localized to neuronal cell bodies and dendrites in various brain regions21. TrkA and p75NTR are co-expressed on the cortical and striatal neurons31,32. A study in cell culture also demonstrated that BDNF can activate ILK-Akt through stimulating TrkA/p75NTR heteroreceptor12. We therefore investigated whether the expression of TrkA and p75NTR is co-located with ILK in the mPFC and NAc core, regions that showed changes in BDNF/ILK expression. The dual immunofluoresence staining revealed that TrkA and p75NTR expression are co-distributed with ILK expression in the mPFC and NAc core (Fig. 6). This suggests that ILK might be activated by BDNF through stimulation of TrkA/p75NTR heteroreceptor.
Discussion
The present study has shown that long-term behavioral sensitization to cocaine is accompanied by increases in BDNF, TrkB, p75NTR, ILK and phospho-Ser473 Akt protein levels in the mPFC and NAc core — two brain areas that have been demonstrated to be intimately involved in cocaine abuse. Moreover, combined pergolide/ondansetron treatment blocked either the behavioral alterations or the increases in the above signaling molecules. Although cocaine sensitization is known to produce long-lasting changes in behavior and molecules related to synaptic plasticity19,33,34, our results first suggested an involvement of the BDNF-TrkA/p75NTR-ILK-Akt signaling pathway in cocaine-induced long-lasting behavioral alterations. Importantly, both the sensitization-associated behaviors and molecules could be blocked by the clinically available drugs.
A previous study in PC-12 cells demonstrated that BDNF-mediated activation of ILK-Akt signaling requires co-expression of TrkA and p75NTR receptors12. In vivo studies have shown the co-expression of TrkA and p75NTR receptors on the cortical and striatal neurons31,32. TrkA and p75NTR receptors were thought to often exist on the same neurons, coordinating and modulating neuronal neurotrophin responses by suppressing or enhancing each other’s actions32,35 or by reciprocally modulating the receptor affinity states in the TrkA and p75NTR heteroreceptor complex36. However, whether the cocaine sensitization is also associated with the activation of BDNF-ILK-Akt signaling, particularly, through the activation of TrkA and p75NTR heteroreceptor remains inadequately addressed. Consistent with previous studies stated above, this study demonstrated that p75NTR and TrkA receptors were co-located in the NAc core and mPFC and were also co-located with ILK expression in these two brain areas. However, Western blot demonstrated that p75NTR, but not TrkA expression was upregulated in the mPFC and NAc core, paralleling the increases in ILK expression and Akt Ser473 phosphorylation. Therefore, we hypothesized that: 1) BDNF-dependent activation of ILK-Akt signaling in the mPFC and NAc core may be mediated through TrkA/p75NTR heteroreceptors. It requires only the coordinate increase in p75NTR activation. In contrast, TrkA may only be required to be co-expressed as a coordinator; and 2) enhanced p75NTR activation and subsequent ILK-Akt signaling may play a significant role in cocaine behavioral sensitization and its reversal by combined pergolide/ondansetron treatment.
It is well established that BDNF specifically binds to the tyrosine kinase B (TrkB) receptor and activates various signaling cascades, which include PI3K-dependent activation of Akt where the Thr308 and Ser473 residues become phosphorylated7,37. In this study, consistent with increases in BDNF concentrations, cocaine sensitization parallels increases in the levels of TrkB and phospho-Ser473 Akt, but not phospho-Thr308 in the mPFC and NAc core. Among signaling molecules that regulate Akt phosphorylation, ILK is one of the upstream kinases that can phosphorylate Akt at the Ser473 residue38. The present study demonstrated that changes in ILK protein levels parallel those in the levels of BDNF and phospho-Ser473 Akt following establishment of sensitization. In addition, the change in ILK protein levels parallel the change in ILK enzymatic activity in vivo. A previous study demonstrated that established cocaine sensitization is associated with opposite changes in the PI3K activity levels in the mPFC and NAc core, but pergolide/ondansetron treatment fails to block either of these changes19. These divergent alterations in the status of PI3K are quite different from the parallel changes observed in BDNF-ILK-Akt Ser473 signaling and behavioral sensitization in the present study. Taken together, these observations suggest that: 1) BDNF is an initiator of ILK-Akt signaling which may not need the corresponding changes in TrkB-PI3K signaling to become activated. In contrast, it may only require constitutive PI3K activity to become activated although pergolide/ondansetron treatment blocked TrkB levels in rats that were administered cocaine; and 2) dysregulation of BDNF-TrkA/p75NTR-ILK-Akt signaling may play a significant role in long-term maintenance of cocaine sensitization.
While the discrepancy between PI3K- and ILK-mediated signaling events may be attributed to a number of different factors, the present study suggests that these two events are mediated by different neurotrophin receptors and thus are independent of each other although constitutive PI3K activity may be required. Other PI3K-independent pathways could also participate in BDNF-Akt signaling during cocaine sensitization and its reversal. These transduction pathways may include MAPK; however, in this case, Akt activation is primarily achieved through Thr308 phosphorylation39. Finally, the increased Akt signaling may also be due to an as yet-to-be-identified non-BDNF-dependent signaling molecule. For instance, NMDA or AMPA receptor stimulation also leads to phosphorylation of Akt40,41. Long-term cocaine sensitization is associated with brain region-dependent alterations in phosphorylation of the NR2B and GluR1 subunits of the respective NMDA and AMPA receptors and these changes are blocked by pergolide/ondansetron treatment28. However, this study provided no further evidence on how BDNF was activated and how the BENF-TrkA/p75NTR-ILK-Akt signaling was involved in the long-term behavioral sensitization to cocaine.
Previous studies have demonstrated that addictive drugs induce cAMP increase via activation of dopamine receptors and calcium entry via activation of glutamate NMDA receptors. These events, in turn, activate numerous intracellular signaling cascades7,42,43. Among them, activated CREB contributes to regulation of genes important to the neuroplastic changes, including regulation of BDNF mRNA transcription, translation and translocation to dendrites9,44,45,46. BDNF is secreted locally near active synapses and binds to Trk receptors located on presynaptic and postsynaptic sites. The activated BDNF/Trks signaling can also phosphorylate AMPA receptors and subsequently activates the CREB and may result in progressive BDNF gene expression and release44,47. There are many ways to interfere with signaling involved in BDNF transcription and translation, which subsequently affects BDNF levels and the sensitization-associated synaptic plasticity. Here, pergolide is a DA agonist and its behavioral effects can last for 3-4 hrs in animals48. Previous studies showed that pergolide alone was not sufficient to consistently block the sensitization-associated behavioral and molecular changes28,49. However, pergolide can induce an ‘acute DA withdrawal state’28. 5-HT3 terminal receptors were thought to mediate local stimulatory actions of 5-HT on DA release in the mPFC, striatum and NAc28. Ondansetron is a 5-HT3 antagonist. A previous study suggested that pergolide may evoke a methamphetamine associated memory and that ondansetron can disrupt its reconsolidation50. Thus, modulations of the DA–5-HT3 interactions in the mPFC and NAc core may form a basis for blocking the sensitization-associated behaviors and BDNF/ILK/Akt changes by a pergolide/ondansetron treatment regimen.
In addition to changes in signal transduction, chronic abuse of drugs (e.g., cocaine) can produce persistent structural alterations in the cytoskeleton. These changes include increases in dendritic branching and density of dendritic spine on medium spiny neurons in the NAc and pyramidal cells in the PFC51,52,53. BDNF stimulation can also lead to similar structural changes54,55. Furthermore, ILK can regulate integrin-dependent neurite outgrowth in N1E-115 neuroblastoma cells23 and NGF-stimulated differentiation of PC-12 cells and dorsal root ganglion neurons21. These observations suggest that increased BDNF levels may be associated with the morphological plasticity observed in long-term psychostimulant (cocaine) sensitization through the BDNF-ILK signaling cascade. Precise relationships of this neurobiological process with functional and morphological changes in behavioral sensitization await further elucidation.
In conclusion, this study suggests that the BDNF-TrkA/p75NTR-ILK-Akt signaling pathway may be active in cocaine sensitization and could be associated with neural plasticity in the mPFC and NAc core.
Additional Information
How to cite this article: Zhang, Y. et al. Molecular changes in the medial prefrontal cortex and nucleus accumbens are associated with blocking the behavioral sensitization to cocaine. Sci. Rep. 5, 16172; doi: 10.1038/srep16172 (2015).
References
Herman, M. A. & Roberto, M. The addicted brain: understanding the neurophysiological mechanisms of addictive disorders. Front Integr. Neurosci. 9, 18 (2015).
Hanlon, C. A. et al. What goes up, can come down: Novel brain stimulation paradigms may attenuate craving and craving-related neural circuitry in substance dependent individuals. Brain Res. doi: 10.1016/j.brainres.2015.02.053. (2015).
Bai, M. et al. Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life. PloS one 7, e46921 (2012).
Zhong, P. et al. BDNF Interacts with Endocannabinoids to Regulate Cocaine-Induced Synaptic Plasticity in Mouse Midbrain Dopamine Neurons. J. Neurosci. 35, 4469–4481 (2015).
Graham, D. L. et al. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat. Neurosci. 10, 1029–1037 (2007).
Bahi, A., Boyer, F. & Dreyer, J. L. Role of accumbens BDNF and TrkB in cocaine-induced psychomotor sensitization, conditioned-place preference and reinstatement in rats. Psychopharmacology 199, 169–182 (2008).
Collo, G., Cavalleri, L. & Spano, P. Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine. Front. Pharmacol. 5, 259 (2014).
Grimm, J. W. et al. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J. Neurosci. 23, 742–747 (2003).
Lu, L., Dempsey, J., Liu, S. Y., Bossert, J. M. & Shaham, Y. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J. Neurosci. 24, 1604–1611 (2004).
Sun, W. L., Eisenstein, S. A., Zelek-Molik, A. & McGinty, J. F. A Single Brain-Derived Neurotrophic Factor Infusion into the Dorsomedial Prefrontal Cortex Attenuates Cocaine Self-Administration-Induced Phosphorylation of Synapsin in the Nucleus Accumbens during Early Withdrawal. Int. J. Neuropsychopharmacol. 18, doi: 10.1093/ijnp/pyu049 (2015).
Huang, E. J. & Reichardt, L. F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609–642 (2003).
Li, M. et al. Infusion of BDNF into the nucleus accumbens of aged rats improves cognition and structural synaptic plasticity through PI3K-ILK-Akt signaling. Behav. Brain Res. 231, 146–153 (2012).
Lykissas, M. G., Batistatou, A. K., Charalabopoulos, K. A. & Beris, A. E. The role of neurotrophins in axonal growth, guidance and regeneration. Curr. Neurovasc. Res. 4, 143–151 (2007).
Reichardt, L. F. Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 361, 1545–1564 (2006).
Chen, Y. et al. Multiple roles of the p75 neurotrophin receptor in the nervous system. J. Int. Med. Res. 37, 281–288 (2009).
Lad, S. P., Peterson, D. A., Bradshaw, R. A. & Neet, K. E. Individual and Combined Effects of TrkA and p75NTR Nerve Growth Factor Receptors a Role for the High Affinity Receptor Site. J. Biol. Chem. 278, 24808–24817 (2003).
Longo, F. M. & Massa, S. M. Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease. Nat. Rev. Drug Discov. 12, 507–525 (2013).
Izzo, E., Martin-Fardon, R., Koob, G. F., Weiss, F. & Sanna, P. P. Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization. Nat, Neurosci. 5, 1263–1264 (2002).
Zhang, X. et al. PI3 kinase is involved in cocaine behavioral sensitization and its reversal with brain area specificity. Biochem. Biophys. Res. Commun. 340, 1144–1150 (2006).
Zhang, Y., Zhang, X., Rabbani, Z. N., Jackson, I. L. & Vujaskovic, Z. Oxidative stress mediates radiation lung injury by inducing apoptosis. Int. J. Radiat. Oncol. Biol. Phys. 83, 740–748 (2012).
Mills, J. et al. Role of integrin-linked kinase in nerve growth factor-stimulated neurite outgrowth. J. Neurosci. 23, 1638–1648 (2003).
Chen, Q. et al. Neural plasticity and addiction: integrin-linked kinase and cocaine behavioral sensitization. J. Neurochem. 107, 679–689 (2008).
Ishii, T., Furuoka, H., Muroi, Y. & Nishimura, M. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells. J. BiolChem. 278, 26970–26975 (2003).
Gary, D. S., Milhavet, O., Camandola, S. & Mattson, M. P. Essential role for integrin linked kinase in Akt-mediated integrin survival signaling in hippocampal neurons. J. Neurochem. 84, 878–890 (2003).
Chun, S. J., Rasband, M. N., Sidman, R. L., Habib, A. A. & Vartanian, T. Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination. J. Cell Biol1. 63, 397–408 (2003).
Porcheri, C., Suter, U. & Jessberger, S. Dissecting integrin-dependent regulation of neural stem cell proliferation in the adult brain. J. Neurosci. 34, 5222–5232 (2014).
Davidson, C., Lee, T. H., Xiong, Z. & Ellinwood, E. H. Ondansetron given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self-administration. Neuropsychopharmacology 27, 542–553 (2002).
Zhang, X. et al. Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors. Neuropsychopharmacology 32, 377–387 (2007).
Lin, S. W. et al. Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system. Exp. Cell Res. 313, 602–613 (2007).
Chen, Q. et al. Integrin-linked kinase is involved in cocaine sensitization by regulating PSD-95 and synapsin I expression and GluR1 Ser845 phosphorylation. J. Mol. Neurosci. 40, 284–294 (2010).
Müller, M. et al. Loss of NGF-TrkA signaling from the CNS is not sufficient to induce cognitive impairments in young adult or intermediate-aged mice. J. Neurosci. 32, 14885–14898 (2012).
Milne, M. R., Haug, C. A., Ábrahám, I. M. & Kwakowsky, A. Estradiol modulation of neurotrophin receptor expression in female mouse basal forebrain cholinergic neurons in vivo. Endocrinology 156, 613–626 (2015).
Timmer, K. M. & Steketee, J. D. Examination of a role for metabotropic glutamate receptor 5 in the medial prefrontal cortex in cocaine sensitization in rats. Psychopharmacology 221, 91–100 (2012).
Szabo, S. T., Fowler, J. C., Froeliger, B. & Lee, T. H. Time-dependent changes in nicotine behavioral responsivity during early withdrawal from chronic cocaine administration and attenuation of cocaine sensitization by mecamylamine. Behav. Brain Res. 262, 42–46 (2014).
Liu, M. et al. (-)-Epigallocatechin-3-Gallate Ameliorates Learning and Memory Deficits by Adjusting the Balance of TrkA/p75NTR Signaling in APP/PS1 Transgenic Mice. Mol. Neurobiol. 49, 1350–1363 (2014).
Ross, G. M. et al. Reciprocal modulation of TrkA and p75NTR affinity states is mediated by direct receptor interactions. Eur. J. Neurosci. 10, 890–898 (1998).
Yao, R. Q. et al. Quercetin attenuates cell apoptosis in focal cerebral ischemia rat brain via activation of BDNF–TrkB–PI3K/Akt signaling pathway. Neurochem. Res. 37, 2777–2786 (2012).
Lee, S. L. et al. Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines. PLoS One 8, e67149 (2013).
Brami-Cherrier, K. 1. et al. Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation. J. Neurosci. 22, 8911–8921 (2002).
Zhu, D., Lipsky, R. H. & Marini, A. M. Co-activation of the phosphatidylinositol-3-kinase/Akt signaling pathway by N-methyl-D-aspartate and TrkB receptors in cerebellar granule cell neurons. Amino. Acids. 23, 11–17 (2002).
Nakai, T. et al. Girdin Phosphorylation Is Crucial for Synaptic Plasticity and Memory: A Potential Role in the Interaction of BDNF/TrkB/Akt Signaling with NMDA Receptor. J. Neurosci. 34, 14995–15008 (2014).
Kalivas, P. W. How do we determine which drug-induced neuroplastic changes are important? Nat. Neurosci. 8, 1440–1441 (2005).
Ortinski, P. I. Cocaine-Induced Changes in NMDA Receptor Signaling. Mol. Neurobiol. 50, 494–506 (2014).
Yamada, K. & Nabeshima, T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J. Pharmacol. Sci. 91, 267–270 (2003).
Chen, J. et al. CREB-BDNF pathway influences alcohol cue-elicited activation in drinkers. Hum. Brain Mapp. 36, 3007–3019 (2015).
Son, Y. et al. Cranial irradiation regulates CREB-BDNF signaling and variant BDNF transcript levels in the mouse hippocampus. Neurobiol. Learn Mem. 121, 12–19 (2015).
Huang, W. et al. AMPK Plays a Dual Role in Regulation of CREB/BDNF Pathway in Mouse Primary Hippocampal Cells. J. Mol. Neurosci. 56, 782–788 (2015).
Clemens, J. A., Okimura, T. & Smalstig, E. B. Dopamine agonist activities of pergolide, its metabolites and bormocriptine as measured by prolactin inhibition, compulsive turning and stereotypic behavior. Arzneimittel-Forschung 43, 281–286 (1993).
Malcolm, R., Kajdasz, D. K., Herron, J., Anton, R. F. & Brady, K. T. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend. 60, 161–168 (2000).
Davidson, C. et al. Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawal. Eur. J. Pharmacol. 565, 113–118 (2007).
Robinson, T. E., Gorny, G., Mitton, E. & Kolb, B. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 39, 257–266 (2011).
Most, D., Workman, E. & Harris, R. A. Synaptic adaptations by alcohol and drugs of abuse: changes in microRNA expression and mRNA regulation. Front. Mol. Neurosci. 7, 85 (2014).
Olive, M. F. & Gass, J. Rewiring the brain: abused drugs and structural plasticity. Front. Pharmacol. 6, 88 (2015).
McFarlane, S. Dendritic morphogenesis: building an arbor. Mol. Neurobiol. 22, 1–9 (2000).
Koo, J. W. et al. Loss of BDNF signaling in D1R-expressing NAc neurons enhances morphine reward by reducing GABA inhibition. Neuropsychopharmacology 39, 2646–2653 (2014).
Acknowledgements
This work was supported by National Natural Science Foundation of China (No. 81071097), Hunan Provincial Natural Science Foundation of China (14JJ3037).
Author information
Authors and Affiliations
Contributions
Y.Z., X.Z. and X.Z. were responsible for the study concept and design. Y.Z. and C.H. contributed to the acquisition of data and assisted with data analysis. Y.Z. drafted the manuscript. X.Z. and X.Z. provided critical revision of the manuscript for important intellectual content. All authors critically reviewed content and approved final version for publication.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Zhang, Y., Zhu, X., Huang, C. et al. Molecular changes in the medial prefrontal cortex and nucleus accumbens are associated with blocking the behavioral sensitization to cocaine. Sci Rep 5, 16172 (2015). https://doi.org/10.1038/srep16172
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep16172
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.